Next Wave (India) is a renowned Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry, recognised for its commitment to quality and innovation. The company is accredited by the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/s) for its Good Manufacturing Practice (GMP) standards. Next Wave (India) operates a state-of-the-art manufacturing facility dedicated to producing non-beta lactam finished dosage forms including tablets, liquid orals, capsules, ointments, gels, and creams. As a reputable CDMO, the company possesses an independent facility for developing new products in accordance with rigorous regulatory requirements, catering to both Indian and global markets, with a presence in various countries across Southeast Asia, the Commonwealth of Independent States (CIS), Latin America (LATAM), and Africa.

Services include:
- Contract Development and Manufacturing (CDMO)
- Machinery & Equipment
- Regulatory Services
- Solid Dosage
- Non Sterile Dosage
- Packaging

Next Wave (India) provides comprehensive solutions tailored to the needs of its pharmaceutical clients, ensuring adherence to regulatory standards and quality benchmarks. For further information, visit nextwaveindia.in.